{"nct_id":"NCT00712881","title":"Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer","status":"COMPLETED","status_verified_date":"2023-07","start_date":"2008-10-13","start_date_type":"ACTUAL","primary_completion_date":"2015-09-17","primary_completion_date_type":"ACTUAL","completion_date":"2015-09-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TEVA"]}